NCT02155803View on ClinicalTrials.gov

ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

November 30, 2015

Conditions
SarcoidosisHypercalcemia Due to Sarcoidosis
Interventions
DRUG

ACTHAR Gel (adrenocorticotropic hormone)

ACTHAR GEL (adrenocorticotropic hormone) 80 units subcutaneously twice weekly for 12 weeks

Trial Locations (1)

12208

Albany Medical College, Albany

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER

NCT02155803 - ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study | Biotech Hunter | Biotech Hunter